Methods for inhibiting cell proliferation in ALK-driven cancers

• 收藏
• 分享

专利权人:

ARIAD Pharmaceuticals; Inc.

发明人:

Sen Zhang,William C. Shakespeare,Victor M. Rivera

申请号：

US14249483

公开号：

US09611283B1

申请日:

2014.04.10

申请国别(地区):

US

年份:

2017

代理人:

摘要：

The invention features a method for treating patients who have an ALK-driven cancer, which is, or has become, refractory to one or more of crizotinib, CH5424802 and ASP3026, or which bears an ALK mutation identified herein, by administering a compound of formula (I) to the patient. The invention also features methods, kits, and compositions for characterizing ALK-driven cancers to determine whether they express an ALK mutant.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/